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 ERCP is the standard procedure for endoscopic biliary therapy. Endoscopic 
approach to the ampulla followed by selective deep biliary cannulation is the first step 
before further therapy. Difficult biliary access can occur during endoscope intubation 
or when attempting selective biliary cannulation in normal or surgically altered 
anatomy. Difficult cannulation increases the risk of post-ERCP adverse events, 
particularly post-ERCP pancreatitis (PEP) and perforation. In normal anatomy, about 
11% of therapeutic ERCPs may be considered difficult biliary cannulation.1 Biliary 
access in patients with surgically altered anatomy, such as Billroth II or Roux-en-Y 
anastomosis, is considered difficult as special instruments and maneuvers are often 
needed. 
Various methods are used to overcome difficult biliary access, including 
advanced ERCP-based techniques using precut or double guidewires (DGW), 
specialized instruments like echoendoscopes or device-assisted enteroscopy, or 
percutaneous approach. These techniques/procedures are more complex and carry 
significant risks, requiring specific training. This consensus aims to develop an 
evidence-based framework for biliary endoscopists to tackle difficult biliary access. 
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Methods 
 Based on literature search through MEDLINE, Cochrane Library, and Embase, a 
planning panel (H.P.W., H.I., R.R., W.C.L., and P.A.) drafted statements on 3 areas: 
difficult biliary access in normal anatomy, difficult biliary access in surgically altered 
anatomy, and EUS- or percutaneous-guided biliary access. The first draft was 
distributed electronically to the panel members who evaluated each statement (Table 
1). A face-to-face meeting was conducted in July 2015 in Taipei, Taiwan, to review 
and discuss the evidence and revise the statements. The members then independently 
voted on each statement via an electronic system. Consensus was considered to be 
achieved when 80% or more of voting members indicated “accept completely” or 
“accept with some reservation.” A statement was rejected when 80% or more of 
voting members “reject completely” or “reject with some reservation.” Finally, 13 
statements achieved consensus. The level of evidence and grade of recommendation 
were rated with the evidence leveling system2 (Table 1). 
Consensus statements 
1. Difficult biliary access is defined as the inability to achieve selective biliary 
cannulation by standard ERCP techniques within 10 minutes or up to 5 cannulation 
attempts, or failure of access to the major papilla.  
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Evidence level: II-A 
Recommendation grade: B 
Voting on recommendation: A, 56%; B, 44%; C, 0%; D, 0%; E, 0% 
 Guidewire-assisted cannulation is considered the standard technique for biliary 
access.3, 4 Increased cannulation time, number of cannulation attempts, and number of 
pancreatic duct injections/cannulations have been associated with increased risk of 
PEP.5-7 Therefore, an upper limit of cannulation time and number of attempts should 
be set to limit PEP risk. A cannulation attempt has been defined as an intentional 
continuous contact with the papilla.7 The definition of difficult cannulation varied 
widely among previous studies; Table 2 summarizes prospective randomized 
controlled trials (RCTs) that reported the definition of difficult cannulation and the 
number of eligible patients and those with difficult cannulation.8-19 A prospective 
study showed that 97.4% of successful primary cannulations were achieved within 5 
attempts, and the risk of PEP jumped from 6.1% to 11.9% with more attempts.7 The 
risk of PEP also significantly increased when cannulation time exceeded 10 minutes 
[odds ratio (OR) 1.76; 95% CI, 1.13-2.74].20 Alternatively, situations such as gastric 
outlet obstruction prevent access to the papilla and subsequent biliary cannulation. 
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The consensus panel defined difficult cannulation as inability to achieve selective 
biliary cannulation by standard ERCP technique within 10 minutes or 5 attempts, or 
failure of access to the major papilla. 
The association between difficult cannulation and higher PEP risk supports for 
tracking cannulation time/attempt and rates of success and adverse events; it also 
underscores the importance of achieving competence during ERCP training and the 
issue of low-volume ERCP providers. An 80% success rate for biliary cannulation has 
been proposed as the goal for ERCP training,21 and one study suggested that 350 to 
400 supervised procedures are required to achieve an 80% success rate in patients 
with native papilla22. It is reasonable to project that even more cases are needed to 
achieve competence in advanced procedures to tackle difficult cannulation (e.g. precut, 
pancreatic stent placement, EUS-guided biliary access, etc); future research is needed 
to better define the minimum volume/outcome requirements for these advanced 
procedures. However, a survey in the United Sates found that graduating fellows 
performed only a median of 140 ERCPs during training and 64% of those fellows did 
not achieve the recommended competency, but 91% planned to perform unsupervised 
ERCP after graduation.23 Low endoscopist ERCP volume (<25 per year) has been 
shown to be associated with a higher failure rate for ERCP and a greater need for 
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post-ERCP hospitalization.24 Further efforts to tackle inadequate ERCP training and 
low provider volume are needed to ensure ERCP quality/safety. 
2. When endoscopic biliary access is difficult, alternative techniques may be required. 
These require specific expertise, and are potentially associated with a higher risk of 
adverse events.  
Evidence level: III 
Recommendation grade: C 
Voting on recommendation: A, 94%; B, 0%; C, 6%; D, 0%; E, 0% 
 When encountering difficult cannulation, one should avoid persisting with the 
same technique to reduce the risk of further injury to the papilla. One option is to 
repeat ERCP in next 24 to 48 hours, or referral to an expert center.20 If a regular 
cannula is initially used, an alternative method is to change to a sphincterotome or a 
bendable-tip catheter.25, 26 Other alternative methods including DGW or precut 
technique, and EUS-guided or percutaneous transhepatic biliary access may be 
applied if the expertise is available. The use of these alternatives may be associated 
with a higher risk of adverse events; however, it is difficult to determine whether the 
higher risk is due to difficult cannulation or to the alternative procedures per se.15, 27 
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These alternative methods are further discussed in the following respective 
statements. 
3. Prophylactic measures against PEP, such as rectal NSAIDs and/or pancreatic stent 
placement, are recommended when standard biliary cannulation fails. 
Evidence level: I-B 
Recommendation grade: A 
Voting on recommendation: A, 94%; B, 0%; C, 6%; D, 0%; E, 0% 
 Difficult cannulation is considered an independent risk factor for PEP.20 A 
prospective study demonstrated that PEP risk was significantly higher when standard 
cannulation failed (11.5%), compared with successful cannulation (2.8%).7 
Techniques such as precut and DGW technique that are used after failed standard 
cannulation may also increase PEP risk. The OR for precut from a recent 
meta-analysis was 2.30 (95% CI, 1.85-2.85),28 and DGW technique appeared to 
increase PEP risk in an RCT.16 
A meta-analysis including 2,133 patients from 7 RCTs showed that rectal 
diclofenac or indomethacin reduced the rates of overall PEP (RR 0.44; 95% CI, 
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0.34-0.57) and of moderate-to-severe PEP (RR 0.37; 95% CI, 0.21-0.63).29 Rectal 
NSAIDs should be administered early when encountering difficult cannulation, 
preferably before moving to alternative techniques such as precut and DGW 
technique. Temporary placement of a pancreatic stent (3F or 5F) to facilitate 
pancreatic drainage for 5 to 10 days has also been shown to reduce PEP risk20, 30, 31, 
and is recommended in patients at high risk of PEP20. An RCT in patients with 
difficult cannulation found that pancreatic stenting significantly reduced the rate of 
PEP from 29.4% in the no-stent group to 12% in the stented group (OR 0.33; 95% CI, 
0.12-0.93).18 Pancreatic stenting also reduced PEP after DGW technique for difficult 
cannulation in an RCT; the rate of PEP was 23% in the no-stent group versus 2.9% in 
the stented group (RR 0.13; 95% CI, 0.02-0.95).19 Leaving the stent for 7 to 10 days 
after precut papillotomy over a pancreatic stent significantly reduced the risk and 
severity of PEP, compared with immediate removal of the stent; the rates of PEP in 
stent-in-place and stent-removed groups were 4.3% versus 21.3% (p < 0.05), and 
those of moderate to severe PEP were 0% versus 12.8% (p < 0.05), respectively.32 
Whether rectal NSAIDs can obviate the need for pancreatic stenting in patients at 
high risk of PEP is not clear and warrants further study. 
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4. Precut or pancreatic guidewire-assisted techniques are appropriate when biliary 
cannulation is difficult. 
Evidence level: I-B 
Recommendation grade: A 
Voting on recommendation: A, 94%; B, 6%; C, 0%; D, 0%; E, 0% 
 When repeated standard cannulation attempts fail to access the bile and 
pancreatic duct, precut involves deroofing the ampullary mucosa to expose biliary 
lumen and is the preferred next-line method.1 A meta-analysis showed that precut 
had higher success rate but similar PEP rate compared with persistent cannulation 
attempts.33 The rates of success and PEP for precut and persistent cannulation were 
86.7% versus 66.7% [relative risk (RR) 1.32; 95% CI, 1.04-1.68] and 6.1% versus 
9.1% (RR 0.62; 95% CI, 0.28-1.36), respectively.33 Another meta-analysis showed 
that the ORs (95% CI) of PEP for immediate precut and precut within 5 or within 10 
minutes of standard cannulation were 0.73 (95% CI, 0.23-2.33), 0.85 (95% CI, 
0.40-1.80), and 0.55 (95% CI, 0.29-1.03), respectively.34 In terms of PEP, 10 minutes 
appears to be the optimum time allowed for standard cannulation technique before 
considering precut. Notably, precut requires expertise and is associated with a higher 
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risk of adverse events, particularly perforation and bleeding, when performed by 
low-volume endoscopists.35 Previous studies suggested that 200 and 100 precuts are 
required to achieve high success and low bleeding rates, respectively.27, 36 
 If guidewire inadvertently enters the pancreatic duct during standard biliary 
cannulation, DGW technique or cannulation over a pancreatic duct stent can be used 
as the next-line modality before precut. DGW technique is performed by placing the 
first guidewire in the pancreatic duct followed by selective biliary cannulation with a 
second guidewire. The first guidewire not only acts as a landmark but also facilitates 
cannulation by straightening the duodenal portion of the common channel. There were 
3 RCTs evaluating DGW technique in difficult cannulation.12, 14, 16 The pooled success 
rate of DGW was 58% (range, 47%-79%);8, 12, 14, 16 the success rate was comparable 
with precut16, 36and was similar to attempts at persistent cannulation12. The pooled 
PEP rate of DGW was 22% (range, 17%-38%);12, 14, 16 the rate of PEP was 
comparable with that of persistent cannulation8, 12 or precut using the fistulotomy 
technique14, but was higher than that of precut using the transpancreatic technique16. 
A complementary technique to DGW with comparable efficacy and safety is to place 
a pancreatic stent after inadvertent access to the pancreatic duct, followed by biliary 
cannulation over the stent.17 If DGW technique or cannulation over a pancreatic duct 
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stent still fails to achieve biliary access, precut over the pancreatic stent or 
transpancreatic septotomy can be used as the next-line modality. 
  
5. All precut techniques achieve a high biliary access rate. Needle-knife fistulotomy 
may be associated with fewer adverse events. 
Evidence level: I-B 
Recommendation grade: A 
Voting on recommendation: A, 56%; B, 38%; C, 6%; D, 0%; E, 0% 
Precut techniques include needle-knife papillotomy (NKP),37 needle-knife 
fistulotomy (NKF),38 and transpancreatic septotomy (TPS)39. NKP starts cutting from 
the papillary orifice toward the 11 o’clock direction.37 By contrast, NKF38 starts at 3 
to 5 mm above the papillary orifice in the same direction as NKP; therefore, NKF 
may be easier to perform when the intraduodenal segment of the bile duct is long or 
prominent. In TPS, after superficial or deep cannulation of the pancreatic duct is 
achieved, a sphincterotome is inserted into the pancreatic duct and cuts the septum 
between bile and pancreatic ducts toward the 11 o’clock direction.39 
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For NKF, NKP, and TPS, the initial success rates were 75.7% to 100%, 73.4% 
to 84.2%, and 95.8% to 100%, respectively38, 40-42 (Table 3). An RCT demonstrated 
comparable success rate between NKF and NKP after failed standard cannulation; the 
primary success rates were 75.7% and 73.4%, and the cumulative success rates after 
repeat cannulation at 48 to 72 hours were 90.5% and 88.6%, respectively.38 Two 
RCTs showed that TPS had higher primary success rate than NKP (100% vs 77%, 
p=0.0143 and 95.9% vs 84.2%, p = 0.01842, respectively).  
Unlike NKP and TPS, NKF does not involve the pancreatic orifice. An RCT 
demonstrated that NKF had a lower risk of PEP than NKP (0% vs 7.6%, p < 0.05).38 
Subgroup analysis of a meta-analysis revealed that NKF significantly decreased the 
risk of PEP (OR 0.27; 95% CI, 0.09-0.82) with an absolute risk reduction of 5% (95% 
CI, 1%-10%), whereas NKP did not (OR 0.89; 95% CI, 0.41-1.92).34 In a 
retrospective study NKF had lower PEP rate than the others; the PEP rates of NKF, 
NKP, and TPS were 2.6%, 21%, and 22.4%, respectively (p = 0.001).40 Therefore, if 
the pancreatic duct can be cannulated, a pancreatic stent should be placed before NKP 
to guide the precut and to reduce PEP risk; a retrospective study showed that 
precutting over a pancreatic stent achieved a higher success rate and a lower adverse 
event rate.20, 44 The stent should be left in place after ERCP; in an RCT the risk of 
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PEP with stent in place versus stent removal after precut over the stent was 4.3% 
versus 21.3% (p=0.027).32 It is also reasonable to leave a pancreatic stent after TPS 
for prophylaxis of PEP.20 There was no significant difference in the rates of bleeding 
and perforation among the 3 techniques (Table 3).38, 40-42 
Collectively, all precut techniques performed in the setting of difficult 
cannulation had success rates of 70% to 90% with similar bleeding and perforation 
rates. NKF had lower PEP rate than other precut techniques. 
 
6. In patients with Billroth II anatomy, both side-viewing and conventional 
forward-viewing endoscopes may achieve comparable biliary access. The use of 
side-viewing endoscopes may be associated with a higher risk of perforation. 
Evidence level: I-B 
Recommendation grade: A 
Voting on recommendation: A, 62.5%; B, 37.5%; C, 0%; D, 0%; E, 0%  
 In Billroth II anatomy, the papilla can be accessed by either side-viewing or 
forward-viewing endoscopes because the afferent limb is relatively short. The main 
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challenge is duodenal intubation with side-viewing duodenoscopes, and cannulation 
without an elevator with forward-viewing endoscopes. A longitudinal case series that 
included 713 patients with Billroth II anatomy undergoing ERCP showed that the 
success rates of duodenal intubation with side-viewing endoscopes was 84%, with an 
overall perforation rate of 1.8%.45 The overall failure rate decreased from 54% in the 
first 5 years to 12% to 22% in the subsequent 25 years.45 A small RCT comparing 
side-viewing and forward-viewing endoscopes in 45 patients with Billroth-II anatomy 
showed no significant difference in the overall success rate (68% and 87%, 
respectively).46 The main reasons for failure with side-viewing endoscopes were 
jejunal perforation (18%), failure to reach the papilla (9%), and severe abdominal pain 
(4.5%). Once the papilla could be reached, side-viewing endoscopes achieved 
cannulation in all patients. This study raises concerns about using side-viewing 
endoscopes as it carried a higher risk of jejunal perforation compared with 
forward-viewing endoscopes (18% vs 0%, p < 0.05).46 However, the rate of jejunal 
perforation of this study was higher than those of other reports (0.7%-10.2%).45, 47 
The higher perforation risk might be attributed to the longer tip of the earlier 
duodenoscopes, and this risk may have become lower with the evolution of endoscope 
design.45 In addition, device-assisted enteroscopy using short single-balloon or 
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double-balloon enteroscopes can also be used in Billroth II anatomy with a high 
success rate.48 
  
7. In surgically altered anatomy, particularly Roux-en-Y anastomosis, device-assisted 
enteroscopy may facilitate access to the papilla or bilio-enteric anastomosis. 
Evidence level: I-A 
Recommendation grade: A 
Voting on recommendation: A, 81%; B, 19%; C, 0%; D, 0%; E, 0% 
Compared with Billroth II anatomy, Whipple’s procedure or Roux-en-Y 
anastomosis poses greater challenges in endoscope intubation and biliary 
cannulation.49, 50 Identifying the afferent limb and reaching the biliary orifice can be 
challenging and potentially complicated by mucosal tears or even perforation. 
Unfavorable angles may render cannulation difficult. 
Device-assisted enteroscopy represents a breakthrough in biliary access for 
patients with surgically altered anatomy. Shah et al reported a large multicenter U.S. 
series using single-balloon, double-balloon, and rotational overtube-assisted 
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enteroscopy for ERCP in patients with surgically altered anatomy.51 The largest 
patient subsets were post Roux-en-Y gastric bypass and Whipple procedure (intact 
papilla) followed by non-transplant Roux-en-Y hepaticojejunostomy. Overall, ERCP 
was successful in 63% of patients. The success rate increased to 88% when the biliary 
orifice was reached. Enteroscopy success was comparable among the 3 techniques.51 
In a more recent series, double-balloon enteroscopy-assisted ERCP was successful in 
95% of patients with prior Roux-en-Y.52 Studies involving single balloon 
endoscopy-ERCP in patients with Roux-en-Y gastric bypass, hepaticojejunostomy or 
Whipple procedure (15 trials, 461 patients) were assessed in a recent meta-analysis. 
Overall, enteroscopy success was 80.9% and procedural success was 61.7%, with 
adverse events occurring in 6.5% of patients.53 
Besides device-assisted enteroscopy, direct puncture into bile duct under EUS 
guidance provides biliary access without the need to access the papilla or bilio-enteric 
anastomosis (see statement 8). Alternatively, ERCP can be performed in an antegrade 
fashion through a transcutaneous gastrostomy into the remnant stomach using a 
duodenoscope. Gastrostomy can be created either by laparoscopy 
(laparoscopy-assisted ERCP)54 or by first using EUS to puncture and insufflate the 
remnant stomach followed by direct percutaneous puncture55, 56. Case series showed a 
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success rate exceeding 90% with this approach,54-56 supporting that transgastric ERCP 
is a valuable addition to biliary endoscopists’ armamentarium for managing patients 
with surgically altered anatomy. 
 
8. EUS-guided biliary access is a viable method for drainage of an obstructed system 
when cannulation via the papilla is unsuccessful by conventional methods, or if the 
papilla is not accessible. 
Evidence level: I-A 
Recommendation grade: A 
Voting on recommendation: A, 81%; B, 19%; C, 0%; D, 0%; E, 0% 
 Endoscopic ultrasound-guided biliary access has emerged as a viable alternative 
when ERCP fails. After EUS-guided puncture of intrahepatic or extrahepatic bile 
ducts from the stomach or duodenum, subsequent biliary therapy can be performed 
either by transluminal or antegrade approaches, or by rendezvous technique. As the 
access site is removed from the papilla, this technique can be applied in patients with 
duodenal stenosis or surgically altered anatomy. Two recent meta-analyses showed 
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that endoscopic ultrasound-guided biliary drainage (EUS-BD) can achieve success 
rates of 90% with adverse event rates around 20%.57, 58 
 
9. Where both EUS-guided biliary access routes are possible, the transduodenal 
approach when appropriate, appears to be safer than transgastric access. 
Evidence level: II-B 
Recommendation grade: B 
Voting on recommendation: A, 81%; B, 19%; C, 0%; D, 0%; E, 0% 
 Transgastric and transduodenal routes can be used for EUS-guided biliary 
access.59, 60 The success and adverse event rates of the 2 access routes are summarized 
in Table 4. A review comparing these 2 access routes in published studies with 25 or 
more cases, including 211 transduodenal and 138 transhepatic cases, found that the 
adverse event rate was higher with the transhepatic route (21.7% vs 9.9%, p= 
<0.01).61 A recent RCT that compared EUS-guided hepaticogastrostomy (EUS-HGS) 
and EUS-guided choledochoduodenostomy (EUS-CDS) in patients with malignant 
distal biliary obstruction found that the 2 approaches were comparable in terms of 
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technical success (96% vs 91% respectively, p= 0.609), quality of life scores, and 
survival (p=0.603). EUS-HGS seemed to have a higher clinical success rate (91% vs 
77%, p= 0.234) and a higher immediate adverse event rate (20% vs 12.5%, p= 0.702) 
than EUS-CDS, but the differences were not statistically significant.62 A recent 
meta-analysis showed that the transduodenal route was safer than the transgastric 
route (pooled OR for adverse events 0.4; 95% CI, 0.18-0.87).58 In another 
meta-analysis, the pooled OR for adverse events for transduodenal versus transgastric 
route was 0.61 (95% CI, 0.36-1.03).57 The higher adverse event rate of HGS, most 
notably bile leak, may be attributed to the longer distance between the puncture site 
and the bile duct through liver parenchyma. Furthermore, stent is placed in the 
common bile duct with CDS but in the intrahepatic bile duct with HGS; segmental 
cholangitis from obstruction of side branches may occur with HGS.63 
 
10. EUS-guided biliary drainage may be performed with high success and an 
acceptable adverse event rate, in experienced hands. 
Evidence level: I-A 
Recommendation grade: A  
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Voting on recommendation: A, 77%; B, 23%; C, 0%; D, 0%; E, 0% 
 A retrospective analysis comparing ERCP and EUS-BD after failed ERCP for 
biliary drainage in cases of malignant distal biliary obstruction found that the 2 
approaches were comparable with respect to success of stent placement (94.23% vs 
93.26%), adverse events (8.65% vs 8.65%), and procedure time.64 The risk of 
pancreatitis appeared to be lower with EUS-BD compared with ERCP (0% vs 4.8%, 
P=0.059).64 Although case series of EUS-BD performed by experienced endoscopists 
suggested EUS-BD is comparable with ERCP in terms of short-term outcomes, 
EUS-BD is less successful and more risky when performed by inexperienced 
endoscopists. A Spanish national survey on EUS-BD conducted in hospitals with an 
experience of fewer than 20 procedures showed that EUS-BD was technically 
successful in only 68.9% of 73 patients with an adverse event rate of 22.6%.65 
Another single-center retrospective study also observed a higher adverse event rate 
among the first 50 cases.66 Taken together, EUS-BD is still relatively nascent and 
should only be performed by expert endoscopists experienced in this procedure. In 
experienced hands, EUS-BD is a safe and effective salvage procedure for endoscopic 
biliary drainage when transpapillary biliary access has failed or is impossible.59, 60, 67 
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11. Percutaneous transhepatic access is a viable method of biliary intervention when 
endoscopic methods fail or are not appropriate. 
Evidence level: I-B 
Recommendation grade: A 
Voting on recommendation: A, 81%; B, 13%; C, 6%; D, 0%; E, 0% 
In patients with a dilated biliary tract from biliary obstruction, percutaneous 
transhepatic puncture of the bile duct is widely used to achieve biliary access when 
ERCP fails.68 After biliary access is achieved, drainage can be performed by placing 
an external catheter or an internal stent, or by passing a guidewire into the duodenum 
for subsequent rendezvous procedure using a duodenoscope or an enteroscope where 
applicable. 
The technical success rate of this method approaches 100% in cases with 
dilated bile ducts and is expected to exceed 70% with non-dilated bile ducts.69 
Although mild bleeding after transhepatic puncture is common and usually 
self-limiting, severe bleeding may occur. In a nationwide audit in Japan, the rate of 
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severe bleeding requiring transfusion and/or arterial embolization after percutaneous 
transhepatic biliary drainage (PTBD) was 2.3% among 34,606 cases.70 
 
12. Percutaneous transhepatic and EUS-guided biliary access appear comparable in 
terms of efficacy, and may be appropriate in surgically altered anatomy. 
Evidence level: I-B 
Recommendation grade: A 
Voting on recommendation: A, 56%; B, 31%; C, 13%; D, 0%; E, 0% 
A retrospective study comparing EUS-BD and PTBD in patients with distal 
biliary obstruction and failed ERCP found that the clinical success rates were 
comparable (86.4% vs 92.2%, p= 0.4), but PTBD had a higher rate of adverse events 
during the index and re-intervention procedures compared with EUS-BD (70.6% vs 
18.2 %, p< 0.001).71 In an RCT comparing PTBD (n=12) and EUS-BD (n=13) in 
patients with malignant biliary obstruction and failed ERCP, technical and clinical 
success were achieved in all patients without significant differences in the adverse 
event rate and cost.72 However, given limited sample size the study may not have 
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been adequately powered to show a difference. A recent RCT evaluating patients with 
malignant distal biliary obstruction and inaccessible papilla also found that PTBD 
(n=32) and EUS-BD (n=34) had comparable rates of technical (96.9% vs 94.1%) and 
functional success (87.1% vs 87.5%), but patients undergoing EUS-BD had fewer 
adverse events (8.8 % vs 31.2%, p=0.022) and re-interventions (25% vs 54.8%, 
p=0.015).73 However, it should be cautioned that those studies were conducted in 
referral centers by expert endoscopists experienced in EUS-BD, and thus the results 
may not be directly generalizable to other settings; it is important to consider 
availability of expertise when choosing between percutaneous and EUS-guided access. 
Collectively, EUS-guided and percutaneous transhepatic biliary access have 
comparable technical and functional success rates; EUS-guided access may carry a 
lower adverse event rate in experienced hands. The possible choices of endoscopes 
and access routes for biliary access in various scenarios of difficult biliary access are 
summarized in Table 5. 
 
13. In the presence of significant duodenal stenosis, endoscopic balloon dilation 
and/or enteral stenting followed by standard biliary cannulation may be considered. 
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EUS-guided or percutaneous biliary access techniques are alternative first-line 
approaches. 
Evidence level: III 
Recommendation grade: C 
Voting on recommendation: A, 75%; B, 19%; C, 6%; D, 0%; E, 0% 
When the papilla is not accessible due to duodenal stenosis, balloon dilation of 
the stenosis or/and duodenal stenting may enable passage of a duodenoscope and 
subsequent biliary access. The success rate of dilation varied from 0 to 87% in 
previous studies.74-76 Identifying the papilla can be challenging due to post-dilation 
bleeding.74 Dilation also carries a risk of perforation; one study reported perforation in 
1 of 16 patients after dilation of duodenal stenosis for access to papilla.76 If dilation 
alone is insufficient, further placement of a self-expanding metal stent (SEMS) may 
allow passage of the duodenoscope.74, 76 Mutignani et al reported that duodenoscope 
passage through the duodenal SEMS was successful in 63 of 64 patients without stent 
displacement after biliary drainage.74 Placement of a SEMS also palliates 
symptomatic obstruction from duodenal stenosis.75 
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EUS-guided and percutaneous transhepatic biliary accesses are alternative 
approaches in cases with significant duodenal stenosis. Both approaches directly 
puncture the bile duct, obviating the need to access the papilla. A multicenter 
retrospective study suggested that in patients with prior duodenal SEMS placement 
and biliary obstruction, biliary SEMS insertion via EUS-BD may be associated with a 
longer stent patency compared with the transpapillary route, likely due to food 
impaction in the duodenal SEMS.77 Although there has been no prospective study 
comparing biliary access after dilation of duodenal stricture with/without stenting 
versus EUS-guided or percutaneous transhepatic biliary access, the latter might be 
preferable if the duodenal stenosis does not cause significant obstruction requiring 
palliation. 
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Table 1 Classification of evidence levels, recommendation grades, and voting on 
recommendation2 
Level/grade          Description 
Evidence level 
I-A 
I-B 
II-A 
II-B 
III 
 
IV 
 
Evidence from meta-analysis of randomized, controlled trials 
Evidence from at least one randomized, controlled trial 
Evidence from at least one controlled study without randomization 
Evidence from at least one other type of quasi-experimental study 
Evidence from non-experimental descriptive studies, such as 
comparative studies, correlation studies, and case-control studies 
Evidence from expert committee reports or opinions or clinical 
experience of respected authorities, or both 
Recommendation grade 
A 
B 
 
C 
 
D 
Directly based on category I evidence 
Directly based on category II evidence or extrapolated 
recommendation from category I evidence 
Directly based on category III evidence or extrapolated 
recommendation from category I or II evidence 
Directly based on category IV evidence or extrapolated 
recommendation from category I, II, or III evidence 
Voting on recommendation 
A 
B 
C  
D 
E 
Accept completely 
Accept with some reservation 
Accept with major reservation 
Reject with reservation 
Reject completely 
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT 42 
Table 2 Definition and incidence of difficult cannulation in randomized controlled 
trials 
First author (year) Definition of difficult 
cannulation 
No. of difficult 
cannulation/no. of 
eligible subjects 
 
Randomly 
assigned 
intervention 
(N) 
Maeda S (2003)8 >10 min 53/107 (49.5%) DGW (27) 
PC (26) 
Tang SJ (2005)9 >12 min (7 by trainee and 5 
by faculty) 
62/642 (9.7%) NKP (32) 
PC (30) 
Zhou PH (2006)10 >10 min 
>3 PD cannulation 
91/948 (9.6%) NKP (43) 
PC (48) 
Cennamo V (2009)11 >5 min 
>3 PD cannulation 
146/842 (17.3%) NKP (36) 
PC (110) 
Herreros de Tejada A (2009)12 >5 attempts 188/845 (22.2%) DGW (97) 
PC (91) 
Manes G (2009)13 >10 min 
>5 PD injection 
158/1654 (9.6%) Early NKF (80) 
Late NKF (78)  
Ito K (2010)19  >5 attempts 108/1451 (7.4%) PD stent (35) 
No stent (35) 
Angsuwatcharakon P (2012)14 >15 min (5 by trainee 10 min 
by faculty) 
44/426 (10.3% ) 
 
DGW (23) 
NKF (21) 
Coté GA (2012)17 
 
>6 min 
>3 PD injection or 
cannulation  
87/442 (19.7%) DGW (42) 
PD stent (45) 
Lee TH (2012)18  >10 min 
>5 PD cannulation 
>10 attempts 
101/1522 (6.6%) PD stent (50) 
No stent (51) 
Swan MP (2013)15 >10 min* 
>10 attempts* 
>4 PD cannulation* 
73/464 (15.7%) NKP (39) 
PC (34) 
Yoo YW (2013)16 >10 attempts 
>10 min 
71/1349 (5.2%) 
 
DGW (34) 
TPS (37) 
Zang J (2014)42 >10 min 
>5 PD cannulation 
164/1181 (13.9%) 
 
TPS (73) 
NKP (76) 
Total 1346/11873 (11.3%)  
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min, minute; PD, pancreatic duct ; DGW, double guidewire technique; NKP, needle knife 
papillotomy; PC, persistent standard cannulation; PD, pancreatic duct; TPS, transpancreatic 
septotomy 
*By trainee and faculty: >5 minutes, >5 attempts, >2 PD cannulation, respectively.  
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Table 3 Success and adverse event rates of the 3 precut techniques in patients with failed standard cannulation 
First author (year) Study design Technique Initial 
success 
Success after 
second attempt 
Pancreatitis Bleeding Perforation 
Katsinelos P (2012)40 Retrospective NKF 
NKP 
TPS 
92.3% 
83.7% 
100% 
(p - NS) 
98.7% 
97.7% 
NA 
(p - NS) 
2.6% 
21% 
22.4% 
(p<0.05) 
5.2% 
3.9% 
0% 
(p - NS) 
0% 
0.8% 
0% 
(p - NS) 
Horiuchi A (2007)41 Retrospective NKF 
NKP 
TPS 
100% 
90% 
95.8% 
(p - NS) 
NA 
100% 
100% 
0% 
3.3% 
2.1% 
(p - NS) 
0% 
6.7% 
0% 
(p - NS) 
0% 
0% 
0% 
(p - NS) 
Mavrogiannis C (1999)38 RCT NKF 
NKP 
75.7% 
73.4% 
(p - NS) 
90.5% 
88.6% 
(p - NS) 
0% 
7.6% 
(p<0.05) 
6.8% 
5.1% 
(p - NS) 
2.7% 
2.5% 
(p - NS) 
Catalano MF (2004)43 RCT NKP 75% NA 12.5% 6.3% 0% 
  TPS 94% NA 3.2% 0% 0% 
   (p-NS)  (p-NS) (p-NS)  
Zang J (2014)42 RCT NKP 
TPS 
84.2% 
95.9% 
(p<0.05) 
NA 
NA 
6.6% 
6.8% 
(p - NS) 
3.9% 
1.4% 
(p - NS) 
0% 
0% 
(p - NS) 
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NKF, needle knife fistulotomy; NKP, needle knife papillotomy; TPS, transpancreatic septotomy; NA, not available; NS, not significant; RCT, 
randomized controlled trial.
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Table 4 Comparison of transgastric and transduodenal routes for EUS-guided biliary access 
First author (year) Design 
Patient number 
(Transgastric/ 
transduodenal) 
Transgastric vs transduodenal 
Success, n (%)        Adverse events, n (%) 
Dhir V (2013)78 Retrospective 
17/18 
16 (94.1%) vs 18 (100%) Bile leak: 2 (11.7%) vs 0 
Pneumoperitoneum: 
2 (11.7%) vs 0 
Dhir V (2014)61 Retrospective 
36/32 
34 (94.4%) vs 31 (96.8 %) 11 (30.5%) vs 3 (9.3%)* 
Kawakubo K (2014)59 Retrospective 
20/44 
19 (95%) vs 42 (95%) 6 (30%) vs 6 (14%)  
Poincloux L(2015)66 Retrospective 
71/30 
66 (94.3 %) vs 27 (93.1%) 10 (14.1%) vs 2 (6.7%) 
Artifon E (2015)62 Prospective  
25/24 
22 (91%) vs 17 (77%) 5 (20%) vs 3 (12.5%) 
*P<0.05. 
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Table 5 Choice of endoscopes and access routes in various scenarios of difficult biliary 
access 
 Difficult 
cannulation in 
normal anatomy 
Billroth II anatomy  Roux-en-Y 
anastomosis 
Duodenoscope Yes Yes No 
Forward-viewing upper 
endoscope 
No Yes No 
Device-assisted enteroscope No Yes (in a long 
afferent limb) 
Yes 
EUS-guided biliary drainage Yes Yes Yes 
Percutaneous biliary drainage Yes Yes Yes 
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ACRONYMS: 
ERCP: endoscopic retrograde cholangiopancreatography 
PEP: post-ERCP pancreatitis 
DGW: double guidewire 
RCT: randomized controlled trial 
EUS: endoscopic ultrasound 
RR: relative risk 
OR: odds ratio 
CI: confidence interval 
NKP: needle knife papillotomy 
NKF: needle knife fistulotomy 
TPP: transpancreatic precut 
NSAID: nonsteroidal anti-inflammatory drug 
EUS-BD: endoscopic ultrasound-guided biliary drainage 
EUS-HGS: endoscopic ultrasound-guided hepaticogastrostomy 
EUS-CDS: endoscopic ultrasound-guided choledochoduodenostomy 
PTBD: percutaneous transhepatic biliary drainage 
SEMS: self-expanding metal stent 
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